Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip R Greipp

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
British Journal of Haematology|September 10, 2011
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03Susanna J Jacobus, Shaji Kumar, Hajime Uno, et al.
Mayo Clinic Proceedings|July 13, 2004
Clinical course of patients with relapsed multiple myelomaShaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Blood|August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasoneShaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Cancer Research|February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group studyRafael Fonseca, David Harrington, Martin M Oken, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Blood|November 29, 2002
POEMS syndrome: definitions and long-term outcomeAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Mayo Clinic Proceedings|January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myelomaShaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosisS Vincent Rajkumar, Ruben A Mesa, Rafael Fonseca, et al.
Mayo Clinic Proceedings|January 17, 2003
Review of 1027 patients with newly diagnosed multiple myelomaRobert A Kyle, Morie A Gertz, Thomas E Witzig, et al.
Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|September 10, 2011
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03Susanna J Jacobus, Shaji Kumar, Hajime Uno, et al.
Mayo Clinic Proceedings|July 13, 2004
Clinical course of patients with relapsed multiple myelomaShaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Blood|August 24, 2011
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasoneShaji K Kumar, Hajime Uno, Susanna J Jacobus, et al.
Cancer Research|February 7, 2002
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group studyRafael Fonseca, David Harrington, Martin M Oken, et al.
American Journal of Hematology|August 24, 2010
Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myelomaKristen Detweiler-Short, Suzanne Hayman, Morie A Gertz, et al.
Blood|November 29, 2002
POEMS syndrome: definitions and long-term outcomeAngela Dispenzieri, Robert A Kyle, Martha Q Lacy, et al.
Mayo Clinic Proceedings|January 17, 2003
Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myelomaShaji Kumar, Morie A Gertz, Angela Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosisS Vincent Rajkumar, Ruben A Mesa, Rafael Fonseca, et al.
Mayo Clinic Proceedings|January 17, 2003
Review of 1027 patients with newly diagnosed multiple myelomaRobert A Kyle, Morie A Gertz, Thomas E Witzig, et al.
Blood|November 3, 2007
Improved survival in multiple myeloma and the impact of novel therapiesShaji K Kumar, S Vincent Rajkumar, Angela Dispenzieri, et al.
Pageof 12